Werdelin LM - Search Results

1

Effects of dopaminergic treatment on bladder function in Parkinson's disease.

Winge K, Werdelin LM, Nielsen KK, Stimpel H. Winge K, et al. Among authors: werdelin lm. Neurourol Urodyn. 2004;23(7):689-96. doi: 10.1002/nau.20054. Neurourol Urodyn. 2004. PMID: 15382192 Clinical Trial.

2

Prevalence of bladder dysfunction in Parkinsons disease.

Winge K, Skau AM, Stimpel H, Nielsen KK, Werdelin L. Winge K, et al. Neurourol Urodyn. 2006;25(2):116-22. doi: 10.1002/nau.20193. Neurourol Urodyn. 2006. PMID: 16402391

3

Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus.

Winge K, Nielsen KK, Stimpel H, Lokkegaard A, Jensen SR, Werdelin L. Winge K, et al. Mov Disord. 2007 Jan 15;22(2):220-5. doi: 10.1002/mds.21253. Mov Disord. 2007. PMID: 17133504

4

[Neurogenic bladder disturbances].

Winge K, Werdelin LM, Iversen-Hansen R. Winge K, et al. Among authors: werdelin lm. Ugeskr Laeger. 2001 Sep 17;163(38):5161-7. Ugeskr Laeger. 2001. PMID: 11577518 Review. Danish.

5

Constipation in neurological diseases.

Winge K, Rasmussen D, Werdelin LM. Winge K, et al. Among authors: werdelin lm. J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):13-9. doi: 10.1136/jnnp.74.1.13. J Neurol Neurosurg Psychiatry. 2003. PMID: 12486259 Free PMC article. Review.

6

Proteomic investigations of the ventriculo-lumbar gradient in human CSF.

Simonsen AH, Bech S, Laursen I, Salvesen L, Winge K, Waldemar G, Werdelin L, Nielsen JE, McGuire JN, Hjermind LE. Simonsen AH, et al. J Neurosci Methods. 2010 Aug 30;191(2):244-8. doi: 10.1016/j.jneumeth.2010.06.017. Epub 2010 Jun 25. J Neurosci Methods. 2010. PMID: 20599557

7

Free-living energy expenditure reduced after deep brain stimulation surgery for Parkinson's disease.

Jorgensen HU, Werdelin L, Lokkegaard A, Westerterp KR, Simonsen L. Jorgensen HU, et al. Clin Physiol Funct Imaging. 2012 May;32(3):214-20. doi: 10.1111/j.1475-097X.2011.01079.x. Epub 2011 Dec 28. Clin Physiol Funct Imaging. 2012. PMID: 22487156

8

Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand.

Løkkegaard A, Werdelin LM, Friberg L. Løkkegaard A, et al. Among authors: werdelin lm. Eur J Nucl Med Mol Imaging. 2002 Dec;29(12):1623-9. doi: 10.1007/s00259-002-0938-7. Epub 2002 Sep 13. Eur J Nucl Med Mol Imaging. 2002. PMID: 12458397

9

[Deep brain stimulation of therapy-refractory, disabling dystonia. Danish Society of Movement Disorders (Danmodis)].

Hjermind LE, Løkkegaard A, Werdelin LM, Regeur L, Jespersen B, Madsen FF, Badakhshani K, Dupont E, Sunde NA, Sørensen JC, Ostergaard K, Karlsborg M. Hjermind LE, et al. Among authors: werdelin lm. Ugeskr Laeger. 2005 Mar 21;167(12-13):1378. Ugeskr Laeger. 2005. PMID: 15832699 Danish. No abstract available.

10

Inherited and de novo mutations in sporadic cases of DYT1-dystonia.

Hjermind LE, Werdelin LM, Sørensen SA. Hjermind LE, et al. Among authors: werdelin lm. Eur J Hum Genet. 2002 Mar;10(3):213-6. doi: 10.1038/sj.ejhg.5200782. Eur J Hum Genet. 2002. PMID: 11973627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters